Testing for variants in GLP1R, GIPR, FTO, and MC4R genes helps your provider tailor treatment to your unique biology, potentially improving both weight loss and long-term adherence
If you are curious about Saxenda or any other weight loss drug, talk to your healthcare provider about whether or not these treatment options are right for you
Rise of Dual and Triple Agonists: Beyond GLP-1, newer drugs target GIP and glucagon receptors for enhanced efficacy (e.g., Tirzepatide, Retatrutide)
The test ($99 add-on after first month) provides 150+ personalized insights that help your provider optimize your medication strategy so you stay on track during trips
The FDA reportedly contacted the manufacturer suggesting that the drug had not been marketed in a truthful and non-misleading way
NEW ORLEANS The rise in use of diabetes medications and continuous glucose monitoring had led to new challenges for treating pregnant women with diabetes